This drug may have a shot at both women’s health disorders and prostate cancer By: MarketWatch October 11, 2017 at 11:34 AM EDT If successful, the drug should be safer, work better and be more convenient to take than current options, the company said. Read More >> Related Stocks: AbbVie Allergan Plc Myovant Sciences Ltd Neurocrine Bioscienc Obseva Sa Pfizer
